BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10454515)

  • 1. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.
    Singer A; Wonnemann M; Müller WE
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1363-8. PubMed ID: 10454515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways.
    Wonnemann M; Singer A; Müller WE
    Neuropsychopharmacology; 2000 Aug; 23(2):188-97. PubMed ID: 10882845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperforin--antidepressant activity by a novel mechanism of action.
    Müller WE; Singer A; Wonnemann M
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S98-102. PubMed ID: 11518085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE
    Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products.
    Schulte-Löbbert S; Holoubek G; Müller WE; Schubert-Zsilavecz M; Wurglics M
    J Pharm Pharmacol; 2004 Jun; 56(6):813-8. PubMed ID: 15231048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperforin activates nonselective cation channels (NSCCs).
    Treiber K; Singer A; Henke B; Müller WE
    Br J Pharmacol; 2005 May; 145(1):75-83. PubMed ID: 15723093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hyperforin in the pharmacological activities of St. John's Wort.
    Zanoli P
    CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
    Bouron A; Lorrain E
    Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vesicular uptake of monoamines by hyperforin.
    Roz N; Mazur Y; Hirshfeld A; Rehavi M
    Life Sci; 2002 Sep; 71(19):2227-37. PubMed ID: 12215370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
    Wonnemann M; Singer A; Siebert B; Müller WE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S148-51. PubMed ID: 11518066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
    Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S
    J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Hypericum perforatum (St. John's wort) on passive avoidance in the rat: evaluation of potential neurochemical mechanisms underlying its antidepressant activity.
    Misane I; Ogren SO
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S89-97. PubMed ID: 11518084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
    Leuner K; Kazanski V; Müller M; Essin K; Henke B; Gollasch M; Harteneck C; Müller WE
    FASEB J; 2007 Dec; 21(14):4101-11. PubMed ID: 17666455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
    Buchholzer ML; Dvorak C; Chatterjee SS; Klein J
    J Pharmacol Exp Ther; 2002 May; 301(2):714-9. PubMed ID: 11961077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperforin as a possible antidepressant component of hypericum extracts.
    Chatterjee SS; Bhattacharya SK; Wonnemann M; Singer A; Müller WE
    Life Sci; 1998; 63(6):499-510. PubMed ID: 9718074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular neurobiology of hyperforin.
    Bouron A
    Phytother Res; 2024 Feb; 38(2):636-645. PubMed ID: 37963759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperforin stimulates intracellular calcium mobilisation and enhances extracellular acidification in DDT1-MF2 smooth muscle cells.
    Koch E; Chatterjee SS
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S70-3. PubMed ID: 11518080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort.
    Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J
    J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of St. John's wort extract and hyperforin on 5 HT uptake and efflux in human blood platelets.
    Uebelhack R; Franke L
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S146-7. PubMed ID: 11518065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.